[Treatment of an extraneural metastasized medulloblastoma].
We report a patient with a history of a previously treated medulloblastoma, now presenting with generalized osseous metastases. Currently there is a complete remission under continuous therapy with VP-16. Since the frequency of systemic metastases in patients with medulloblastoma is approximately 5%, we recommend a more extensive initial evaluation in these patients.
Huber
A
A
Kinderklinik, Johannes Gutenberg-Universität Mainz.
Bohl
J
J
Gutjahr
P
P
D000328:Adult; D001859:Bone Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000556:secondary*; D002528:Cerebellar Neoplasms; D005047:Etoposide / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008527:Medulloblastoma / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000556:secondary*; D011877:Radionuclide Imaging
D005047:Etoposide
Behandlung eines extraneural metastasierten Medulloblastoms.